Abstract
Alphaxalone-alphadolone (Althesin), diluted and administered as a controlled infusion, was used as a sedative for 30 patients in an intensive therapy unit. This technique allowed rapid and accurate control of the level of sedation. It had three particularly useful applications: it provided “light sleep,” allowed rapid variation in the level of sedation, and enabled repeated assessment of the central nervous system.
Sedation was satisfactory for 86% of the total time, and no serious complications were attributed to the use of the drug. Furthermore, though alphaxalone-alphadolone was given for periods up to 20 days there was no evidence of tachyphylaxis or delay in recovery time.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arora M. V., Carson I. W., Dundee J. W. Alterations in response to somatic pain associated with anaesthesia. XXI. Althesin (CT1341). Br J Anaesth. 1972 Jun;44(6):590–592. doi: 10.1093/bja/44.6.590. [DOI] [PubMed] [Google Scholar]
- Morgan M., Whitwam J. G., Page P. Influence of subnarcotic doses of Althesin (CT1341) on pain induced by two types of pain stimulus. Br J Anaesth. 1973 May;45(5):481–485. doi: 10.1093/bja/45.5.481. [DOI] [PubMed] [Google Scholar]
- Pickerodt V. W., McDowall D. G., Coroneos N. J., Keaney N. P. Effect of althesin on cerebral perfusion, cerebral metabolism and intracranial pressure in the anaesthetized baboon. Br J Anaesth. 1972 Aug;44(8):751–757. doi: 10.1093/bja/44.8.751. [DOI] [PubMed] [Google Scholar]
- Turner J. M., Coroneos N. J., Gibson R. M., Powell D., Ness M. A., McDowall D. G. The effect of althesin on intracranial pressure in man. Br J Anaesth. 1973 Feb;45(2):168–172. doi: 10.1093/bja/45.2.168. [DOI] [PubMed] [Google Scholar]